According to the Market Statsville Group (MSG), the Global Brain MRI Scan Market size is expected to grow at a CAGR of 6.1% from 2025 to 2033.

Due to the increasing number of cases of tumors, cancers, injuries, and other types of diseases as well as the result of ongoing investments being made in the establishment, is driving the growth of brain MRI scan market. The functional magnetic resonance imaging system uses light as part of its non-invasive disease and injury detection and investigation method, making it easier for medical professionals to treat patients with these conditions. The MRI was developed as a result of the drawbacks and dangers associated with radioactive technology's UV radiation.

COVID-19 Impact on the Global Brain MRI Scan Market

The COVID-19 pandemic significantly impacted the healthcare sector. It had a negative impact on the market for brain MRI scans. Pandemic lockdowns and isolation make diagnosis, management, and therapy more challenging. The government's implementation of the lockdown and social isolation measures to contain the COVID-19 pandemic outbreak resulted in the emergence of several difficulties, including service denial, the suspension or cancellation of various operations, the cancellation or postponement of brain diagnostic services, stifling business growth, and the suspension of new developments, further restricting the industry's growth. However, adopting advanced technologies creates a positive outlook for the market. The MRI scan market, supported by the European Union, was improved with the introduction of artificial intelligence. Around 20,000 CT scans are scanned using artificial intelligence MRI scanners. Moreover, fewer COVID-19 patients are being treated globally, leading to more people needing wound care treatments. Consequently, after COVID-19, the market for brain MRI scans will expand quickly.

Global Brain MRI Scan Market Dynamics

Drivers: Increasing Demand for High-Field Strength MRI Machines

The global brain MRI scan market is significantly driven by the growing demand for high-field strength MRI machines, owing to their enhanced diagnostic accuracy and performance in a wide range of clinical applications. Numerous research studies have validated the superior imaging capabilities of these machines, especially in the areas of neurology and musculoskeletal assessment.

Development in this field is advancing rapidly, with several companies receiving regulatory approval for their products. For instance, in November 2020, the U.S. FDA approved GE Healthcare’s SIGNA 7.0T MRI scanner, which can be used in both clinical and research settings. This advancement supports the diagnosis and monitoring of various neurologic and musculoskeletal conditions.

Currently, only a limited number of institutions, such as Mayo Clinic, Brigham and Women’s Hospital, The University of Iowa, and University of Southern California, have installed these high-field MRI systems. These installations have expanded research capabilities and opened new avenues in brain imaging.

While 7T MRI scanners are primarily used for brain imaging due to the current lack of advanced coils for broader applications, ongoing technological developments are expected to overcome this limitation. The development of specialized coils is projected to broaden the clinical use of 7T MRI machines, fueling market growth over the forecast period.

Restraints: Stringent Government Regulations and High Costs

One of the major constraints to market growth is the strict regulatory environment governing the approval and use of MRI systems, particularly for procedures involving brain tumors and malignancies. Governments in several countries impose comprehensive documentation and compliance requirements for the introduction of new imaging technologies. This complex and time-consuming approval process often delays product launches and deters manufacturers from entering the market.

In addition to regulatory barriers, the high cost of MRI systems presents a significant challenge. These costs limit accessibility, especially for patients in low-income regions who may not have insurance or sufficient financial support. As a result, the adoption rate of MRI technology remains lower than its potential, hindering overall market expansion.

Opportunities: Expansion of MRI Facilities and Integration of AI

The growing number of diagnostic centers and the expansion of healthcare infrastructure, particularly in emerging markets, offer substantial growth opportunities for the brain MRI scan market. Universal healthcare coverage in countries such as the U.S., Canada, and several European nations reduces out-of-pocket expenses, thereby encouraging patients to seek regular MRI testing and treatment.

In the U.S., programs like Medicare, Medicaid, and the State Children’s Health Insurance Program (SCHIP) cover approximately 80–90% of medical costs for most citizens. Similarly, Canadian citizens benefit from public healthcare under Medicare. According to the OECD, the U.S. had approximately 34.54 MRI units per million people in 2020, highlighting the widespread availability of this technology.

Further, the integration of artificial intelligence (AI) into MRI systems is expected to significantly enhance imaging efficiency, accuracy, and speed, thus contributing to market growth.

Emerging countries are also witnessing infrastructural developments in MRI technology. For example, in November 2021, India’s National Brain Research Centre (NBRC) in Manesar, Haryana, inaugurated a state-of-the-art MRI facility featuring the Siemens PRISMA 3T MRI scanner. This development underscores the growing adoption of advanced MRI systems in research and clinical settings across developing nations.

Scope of the Global Brain MRI Scan Market

The study categorizes the brain MRI scan market based on machine type, field of strength, and brain disorder area at the regional and global levels.

By Machine Type Outlook (Sales, USD Million, 2025-2033)

• Closed MRI System
• Open MRI System

By Field Strenght Outlook (Sales, USD Million, 2025-2033)

• Low field MRI System
• Mid field MRI System
• High field MRI System

By Brain Disorder Outlook (Sales, USD Million, 2025-2033)

• Brain Tumor
• Dementia
• Alzheimer’s Disease
• Parkinson’s Disease
• Epilepsy And Seizure
• Stroke
• Multiple Sclerosis
• Others

By Region Outlook (Sales, USD Million, 2025-2033)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • The Netherlands
  • Norway
  • Czech Republic
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA

North America Accounted for the Largest Market Share by Region

North America held the largest share of the brain MRI scan market and is expected to maintain its dominance throughout the forecast period. This leadership is driven by the region’s early adoption of advanced technologies, continuous product innovations, and strong presence of key market players.

The region benefits from a well-established healthcare infrastructure and widespread access to cutting-edge MRI systems, enabling faster and more accurate diagnoses. Furthermore, supportive regulatory frameworks and significant investments in healthcare technology further fuel market growth.

Key Market Players in the Global Brain MRI Scan Market

The Brain MRI Scan Market is a significant competitor and extremely cutthroat in the sector are using strategies including product launches, partnerships, acquisitions, agreements, and growth to enhance their market positions. Most sector businesses focus on increasing their operations worldwide and cultivating long-lasting partnerships.

Major key players in the global Brain MRI Scan Market are:

• GE Healthcare
• Siemens AG
• Toshiba Corporation
• Aurora Imaging Technologies, Inc.
• Koninklijke Philips N.V.
• Esaote SPA
• Sanrad Medical Systems Pvt ltd
• Fujifilm
• Canon Medical Systems Corporation
• Hyperfine
• Time Medical Holding

Recent Development

• In November 2025, GE Healthcare launched a new artificial intelligence platform called SIGNA Experience, which incorporates AI- and deep learning-based software with magnetic coils that are easy to position. The platform aims to assist staff in preparing GE Healthcare's SIGNA scanners and obtaining clear diagnostic images as quickly as possible.
• In April 2025, Imeka collaborated with GE Healthcare to expand MRI technology in brain health. GE Healthcare and Imeka will work together to incorporate Imeka's non-invasive neuroimaging technology into the BrainWave advanced diffusion processing package. This integration will enable researchers and clinicians to conduct a more thorough analysis of diffusion MRI signals in the brain.
• In March 2025, Cerebriu and Siemens Healthineers entered into a partnership in which Cerebriu's patented Smart Protocol for Brain MRI-workflow automation software will be integrated with Siemens Healthineers' MRI machines. The partnership showcases a strong collaboration between innovators and forward-thinking OEMs, allowing healthcare providers to enhance patient care during imaging procedures.

Key Issues Addressed

• What is the market size by various segmentation of the brain MRI scan market management by region and its respective countries?
• What are the customer buying behavior, key takeaways, and Porter's 5 forces of the brain MRI scan market?
• What are the key opportunities and trends for manufacturers involved in brain MRI scan market management supply chain?
• What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
• What and how regulations, schemes, patents, and policies are impacting the growth of the market?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• The market player positioning, top winning strategies by years, company product developments, and launches will be?
• How has COVID-19 impacted the demand and sales ofbrain MRI scan management in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.